Mechanistically, we identified that COL6A2 promotes the proliferation, migration, and invasion of ccRCC cells by inducing EMT via modulation of the Wnt/β-catenin signaling in an integrin-dependent manner. Here, COL6A2 is linked to nonpapillary renal cell carcinoma.